Clinical Trial Update: Neural Autoantibody Prevalence in New-onset Focal Seizures of Unknown Etiology

View source ↗

Summary

A clinical trial is evaluating how common neural autoantibodies are in people with new-onset focal seizures of unknown etiology, and it is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Encephalitis
• Epilepsy

Snippet

Sponsor: Shen Chun-Hong | Conditions: Epilepsy, Encephalitis Autoimmune | Status: RECRUITING